COVID-19 (SARS-CoV-2) in Urine and Semen

NCT ID: NCT04446169

Last Updated: 2021-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

43 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-27

Study Completion Date

2021-09-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is part of the current global emergency scenario due to infection with Coronavirus, SARS-CoV-2 as indicated by the international taxonomy. Study aim is to investigate the possibility of the presence of the virus within the seminal fluid and in the urine of infected patients, both during the acute phase and remotely. Current evidences show that Coronaviruses can be present inside the testicle and sperm in other species, such as in feline and avian models.

In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab.

Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine.

A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer. The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind.

The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is part of the current global emergency scenario due to infection with Coronavirus, SARS-CoV-2 as indicated by the international taxonomy. Study aim is to investigate the possibility of the presence of the virus within the seminal fluid and in the urine of infected patients, both during the acute phase and remotely. Current evidences show that Coronaviruses can be present inside the testicle and sperm in other species, such as in feline and avian models.

In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab.

Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine.

A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer.

According to results obtained, follow up will be tailored to patients (assessment for COVID 19 infections and/or further analysis/folliow-up in case of abnormal findings) The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind.

The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SARS-CoV 2 Sexual Function and Fertility Disorders Urinary Function Disorders Urine Semen

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SARS-CoV 2 Patients

Patients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections

SARS-CoV 2 RNA PCR Urine

Intervention Type DIAGNOSTIC_TEST

Search for SARS-CoV 2 RNA in urine through PCR

SARS-CoV 2 RNA PCR Semen

Intervention Type DIAGNOSTIC_TEST

Search for SARS-CoV 2 RNA in Semen through PCR

Semen Qualitative Analysis

Intervention Type DIAGNOSTIC_TEST

Search for Semen Alterations in patients with past SARS-CoV 2 infection

IIEF-5 questionnaire

Intervention Type DIAGNOSTIC_TEST

IIEF-5 assessment in patients with past SARS-CoV 2 infection

Male Sexual Health Questionnaire (MSHQ)

Intervention Type DIAGNOSTIC_TEST

Male Sexual Health Questionnaire (MSHQ) assessment in patients with past SARS-CoV 2 infection

IPSS questionnaire

Intervention Type DIAGNOSTIC_TEST

IPSS assessment in patients with past SARS-CoV 2 infection

SECRET questionnaire

Intervention Type DIAGNOSTIC_TEST

SECRET questionnaire assessment in patients with past SARS-CoV 2 infection

Interleukin assessment in semen

Intervention Type DIAGNOSTIC_TEST

Assessment of Interleukin presence and quantitative analysis in semen, to study if a previous inflammation/infection due to SARS-CoV 2 in testis was present

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SARS-CoV 2 RNA PCR Urine

Search for SARS-CoV 2 RNA in urine through PCR

Intervention Type DIAGNOSTIC_TEST

SARS-CoV 2 RNA PCR Semen

Search for SARS-CoV 2 RNA in Semen through PCR

Intervention Type DIAGNOSTIC_TEST

Semen Qualitative Analysis

Search for Semen Alterations in patients with past SARS-CoV 2 infection

Intervention Type DIAGNOSTIC_TEST

IIEF-5 questionnaire

IIEF-5 assessment in patients with past SARS-CoV 2 infection

Intervention Type DIAGNOSTIC_TEST

Male Sexual Health Questionnaire (MSHQ)

Male Sexual Health Questionnaire (MSHQ) assessment in patients with past SARS-CoV 2 infection

Intervention Type DIAGNOSTIC_TEST

IPSS questionnaire

IPSS assessment in patients with past SARS-CoV 2 infection

Intervention Type DIAGNOSTIC_TEST

SECRET questionnaire

SECRET questionnaire assessment in patients with past SARS-CoV 2 infection

Intervention Type DIAGNOSTIC_TEST

Interleukin assessment in semen

Assessment of Interleukin presence and quantitative analysis in semen, to study if a previous inflammation/infection due to SARS-CoV 2 in testis was present

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male Sex
* Age\>18 years
* Will to participate to the study
* Documented past infection for SARS-CoV2 (Nasopharyngeal swab positive for SARS-CoV2 RNA)
* Current negative infection for SARS-CoV2 (Two negative Nasopharyngeal swab for SARS-CoV2 RNA, done following WHO guidelines)

Exclusion Criteria

* Age more than 80 years old
* Anejaculation
* Patient's will
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda Ospedaliero-Universitaria Careggi

OTHER

Sponsor Role collaborator

University of Florence

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Simone Morselli

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mauro Gacci, MD

Role: PRINCIPAL_INVESTIGATOR

Careggi University Hospital

Sergio Serni, Prof

Role: STUDY_DIRECTOR

University of Florence

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AOU Careggi

Florence, Tuscany, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17104_oss/2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sex Selection of Human Spermatozoa
NCT05500573 RECRUITING NA
Sperm Motility and IUI Live Birth Rate
NCT06117995 NOT_YET_RECRUITING